REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
31 hedge funds and large institutions have $8.75M invested in REVIVA PHARMA HLDGS INC in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
180% more call options, than puts
Call options by funds: $492K | Put options by funds: $176K
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
11% more funds holding
Funds holding: 28 → 31 (+3)
0.15% more ownership
Funds ownership: 1% → 1.15% (+0.15%)
58% less capital invested
Capital invested by funds: $21M → $8.75M (-$12.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$1.22M |
| 2 |
Millennium Management
New York
|
+$879K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$539K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$425K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$458K |
| 2 |
JP Morgan Chase
New York
|
-$146K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$132K |
| 4 |
Jane Street
New York
|
-$114K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$52.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWM
26
Activest Wealth Management
Aventure,
Florida
| $1.28K | +$2.27K | +50 | New |
|
|
AIC
27
Archer Investment Corporation
Carmel,
Indiana
| $640 | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $499 | +$909 | +20 | New |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $160 | +$273 | +6 | New |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| $64 | -$48.8K | -1,073 | -100% |
|
|
31
JP Morgan Chase
New York
| – | -$146K | -1,933 | Closed |
|
|
32
Marshall Wace
London,
United Kingdom
| – | -$132K | -1,743 | Closed |
|
|
33
Jane Street
New York
| – | -$114K | -1,505 | Closed |
|
|
34
Vontobel Holding
Zurich,
Switzerland
| – | -$52.9K | -700 | Closed |
|
35
Wells Fargo
San Francisco,
California
| – | -$662 | -9 | Closed |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$545 | +12 | New |
|
RVPH Hedge Fund Activity: Q2 2024 in Review
31 of the 6,930 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q2 2024, worth a combined $8.75M — down 58% from $21M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new RVPH positions and 5 closed out — a net gain of 4 holders — while 12 added to existing stakes and 4 trimmed.
The largest buyer was Woodline Partners, adding an estimated $1.22M. The largest seller was Susquehanna International Group, cutting an estimated $458K.
- 31 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q2 2024, up from 28 in Q1 2024.
- Funds reported $8.75M of REVIVA PHARMA HLDGS INC stock for Q2 2024, down 58% quarter-over-quarter.
- 9 funds opened new REVIVA PHARMA HLDGS INC positions in Q2 2024 and 5 closed out, a net change of +4 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q2 2024 was Woodline Partners, an estimated $1.22M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q2 2024 was Susquehanna International Group, an estimated $458K sold.
Based on aggregated 13F filings for Q2 2024.